ph modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-/V-aminoglycoside acetyltransferase
|
|
- Heather Hamilton
- 5 years ago
- Views:
Transcription
1 Journal of Antimicrobial Chemotherapy (1996) 37, ph modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-/V-aminoglycoside acetyltransferase E. Culebras**, J. L. Martinez**, F. Baquero* and J. C. P6rez-Diaz* "Centro Nactonal de Biotecnologia (CSIC), Campus (JAM, Cantoblanco, Madrid; h Servicio de Microbiologia, Hospital Ramon y Cajal, Carretera de Colmenar Km 9,100, Madrid, Spain The kinetic constants of the aminoglycoside-modifying enzyme 6'-/V-aminoglycoside acetyltransferase (AAC(6')IV) from the clinical strain Staphylococcus epidermidis RYC differed depending on whether tobramycin and amikacin (glucosamine group) or gentamicin and netilmicin (garosamine group) were used as substrates. Acetylation of the glucosamine antibiotics was highly susceptible to substrate inhibition which increased with ph whereas the garosamine group compounds showed limited substrate inhibition over a wide ph range. These differences in activity correlated with MIC values of S. epidermidis RYC for different aminoglycosides. Aminosugars moiety and ph markedly influenced the AAC(6')FVaminoglycoside interactions. Introduction Resistance to gentamicin and the related aminoglycosides, tobramycin and kanamycin, which is primarily due to the production of antibiotic-inactivating enzymes, is common in nosocomial strains of staphylococci isolated in hospitals around the world (Graham, 1981; Wiedemann & Kresken, 1984; Guimaraes, Sage & Noone, 1985; Davies, 1994). The recent spread of multiresistant methicillin-resistant staphylococcus (Mulligan &, 1993; Lencastre et al., 1994; Swartz, 1994) may increase this antibiotic resistance problem. In the case of antibiotic-inactivating enzymes, enzymatic modification of an aminoglycoside does not necessarily imply a clinical resistance to this drug. Resistance to an aminoglycoside appears to be a function of the ratio between accumulation and modification velocities of the drug. This ratio is determined by the amount of antibiotic at the site of infection, the permeability characteristics of bacteria, and the activity of the antibiotic-inactivating enzyme. Hence the knowledge of kinetic constant values is essential for the understanding of this process. Several studies with the enzymes aminoglycoside nucleotidyl transferase (2") (Bongaerts & Molendijik, 1984), gentamicin acetyltransferase I (Williams & Northrop, 1978) and kanamycin acetyltransferase (Radika & Northrop, 1984), have shown that aminoglycoside resistance mediated by inactivating enzymes is a function of the hydrolytic constant V^K^. 'Corresponding author /96/ $12.00/ The British Society for Antimicrobial Chemotherapy
2 882 E. Culebras et at. Although environmental ph is known to affect the activities of many antibiotics, including aminoglycosides (Bryan, 1984; Thrupp, 1980), little is known about the effect of this factor on the kinetic constants of antibiotic-inactivating enzymes. Values of ph can change between 5.5 and 7.5 in different tissues of healthy individuals (Livermore & Corkill, 1992), and the range may be even wider in patients suffering infectious diseases (Hamill & Maki, 1986; Gudmundson et al., 1991). It has been shown that changes in both extracellular and intracellular ph affect the expression of several genes (Olson, 1993). In general, bacteria are able to maintain the internal ph constant even when external ph changes by up to 2 units. However, it is known that internal ph cannot be maintained when bacteria are growing under stress conditions (Booth, 1985) and changes in external ph have been found to trigger transient changes of internal ph, which may produce changes in both the expression of certain genes such as the Escherichia coli SOS response (Dri & Moreau, 1994), and the activity of certain enzymes. In the present work, we have determined the kinetic constants of the aminoglycoside-inactivating enzyme 6'-JV-aminoglycoside acetyltransferase (AAC(6')IV) from Staphylococcus epidermidis using antibiotics of clinical interest. We have also evaluated the effect of 6'-aminosugar functional groups and of ph on the kinetic constants. Chemicals Materials and methods The antibiotics were obtained from the following suppliers: gentamicin and netilmicin from Shering Corp., Bloomfield USA, tobramycin from Eli Lilly & Co., Indianapolis USA, and amikacin from Bristol-Squibb Laboratories, Syracuse, USA. The radioactive compounds were obtained from Amersham UK. Lysozyme and lysostaphin were obtained from Sigma Chemical Co., St. Louis, USA. Antibiotic susceptibility tests Antibiotic susceptibility was evaluated by the Mueller-Hinton broth dilution technique, according to the protocols of the National Committee for Clinical Laboratory Standards (NCCLS, 1990). When needed, the medium was buffered at the desired ph with 0.1 M phosphate buffer. Aminoglycoside-modifying enzyme assays Bacterial extracts were prepared and the enzymes were assayed using the phosphocellulose paper-binding technique described previously (Haas & Dowding, 1975). The reaction was allowed to proceed for 30 min at 37 C. In the case of kinetic studies, assay mixtures contained the appropriate substrates, 0.1 M Tris-maleate buffer ph 5.5, 6.5 or 7.5, 10 mm MgCl 2, 2.5 mm dithiothreitol and 1 mm 1- M C-ACCOA (1500 cpm/nmol) in a total volume of 250 nl. Each reaction was started by the addition of 50 /il of the crude bacterial extracts. All kinetic studies were performed at 37 C, and determination of the kinetic constants was made as described (Culebras et al., 1994).
3 ph regulation of AAC(60 activity 883 Kinetic studies of acetyllransferase activity Results The clinical isolate 5. epidermidis RYC13036 (Culebras et al., 1994) harbouring the bifunctional enzyme AAC(6')IV-APH(2") (Le Goffic, Moreau & Masson, 1977) was used in our work. Since acetyltransferase activity is responsible for most of the aminoglycoside resistance in staphylococci, we analyzed the kinetic constants of this enzyme. As Table I shows, the acetyltransferase enzyme had a very high K m value for netilmicin and a very low value for tobramycin both at ph 5.5 and 6.5. At the same ph values, amikacin and gentamicin exhibited intermediate K m values. All these were lower at ph 7.5. At all ph values tested, the enzyme was most active against tobramycin and least active against netilmicin. The value of the V^. constant was also clearly dependent on ph, showing highest values at ph 6.5 using tobramycin, amikacin or gentamicin as substrates. At ph 7.5 these values were slightly lower and they were lower still at ph 5.5. Results with netilmicin were different, with K.^, values rising with increasing ph. As Table I shows, the Knu at ph 7.5 was three times higher than at ph 6.5, whereas at ph 5.5 the activity of the enzyme was nearly undetectable. Substrate inhibition ph influence As substrate inhibition might be relevant for the susceptibility to aminoglycosides of bacteria producing antibiotic-inactivating enzymes, we evaluated the K, of AAC(6')IV to tobramycin, gentamicin, amikacin and netilmicin. The analysis was performed at the same three ph values (5.5, 6.5 and 7.5) previously used for determining the K m and V mmi values. As Figure 1 shows, the type of 6'-aminosugar of the molecule (Figure 2) appeared to have a dramatic effect on the substrate inhibition. The members of the kanamycin family (with a glucosamine-like 6'-aminosugar) showed an inhibition that increased with increasing ph. The opposite was the case for the members of the gentamicin family (groups of aminoglycosides with garosamine) which presented the highest K t values at ph 7.5 (Table II). Also for all ph values tested, the K, values for gentamicin and netilmicin were large, which indicates that substrate inhibition is not significant for members of this family of aminoglycosides. Discussion It has been shown that the hydrolytic constant (V<mJKm) has a close relationship with MIC values for aminoglycoside-inactivating enzymes were compared (Radika & Northrop, 1984). With our strain, this relationship existed when MICs for tobramycin, amikacin and netilmicin, but not gentamicin. The strain used in this study has APH(2") activity, and since this is more active against gentamicin (Bongaerts & Vliegenthart, 1988), the phenotypic behaviour of S. epidermidis RYC13036 towards this antibiotic results from activities of both AAC(6'), and APH(2"), the second being especially active against gentamicin. Substrate inhibition was shown to be relevant for the kanamycins but not for the gentamicins. It has been suggested (Umezawa, Yagisawa & Sama, 1975) that the enzyme AACX60 has two substrate recognition regions, one being the catalytic region, the
4 Table 1. Apparent kinetic constants of AAC(6')IV and MICs of S. epidermidis RYC13036 at different phs Aminoglycoside Tobramycin Gentamicin Netilmicin ph m K m (JIM) ph ph (pmol/mg/min) ph5.5 ph6.5 ph ph b 'mmxf **-m ph ph MIC (mg/l) ph5. 5 ph 6.5 ph7.5 The value was too high to be measured accurately *Since the value of /f» was not obtainable for this antibiotic at ph 5.5. V^,/K m was not determined, but is assumed to be very low because the value for AC was very high w E. re 1 % s.
5 ph regulation of AAC(60 activity 885 ph5.5 ph6.5 ph i itain 1C Gei 20 n * t 1 i 1 i 1/v (mg.ml/pmol) Fignre 1. Kinetics of excess substrate inhibition: The K, values of AAC(6') from S. epidermidis at different phs were calculated using amikacin, tobramycin, netilmicin and gentamicin substrates.
6 886 E. Culebru et at. AMINOHEXOSE(') OH 2, 6 DIAMINE Gentamicin C Tbbramycin Netilmicin NH 2 3AMIN0HEXOSET) 0 (R): NHCCHCHJCHNHJ OH (R): NHCjHg Netilmicin 6AMINE Gentamicin B CHJNHJ GLUCOSAMINE Tbbramycin OH 2AMINE Gentamicin A GAROSAMINE Gentamicin Figure 2. Aminoglycoside structures, relevant features of amikacin, gentamicin, tobramycin and netilmicin are shown. other being involved in substrate inhibition. According to our results, both the \-N substituents and the aminohexose (3") are important for the inhibition. Hence, the glucosamine sugar increases substrate inhibition, since the K, values were much lower for tobramycin and amikacin than for the garosamine-containing aminoglycosides gentamicin and netilmicin. On the other hand, the fact that antibiotics with l-n substitutions (amikacin and netilmicin) had higher K t than their non-substituted counterparts (tobramycin and gentamicin), suggests that the \-N side chain reduces inhibition. The values of ph vary between different tissues, and also depend on the site of infection and underlying patient condition. Metabolic acidosis is a well-known complication of septic shock (Hamill & Maki, 1986). Although acidic ph has been Table II. Effect of ph on K { of different aminoglycosides K(HM) Aminoglycoside ph 5.5 ph 6.5 ph 7.5 Tobramycin Gentamicin Netilmicin
7 ph regulation of AAC(60 activity 887 shown to inhibit the cellular uptake of aminoglycosides (Damper & Epstein, 1981; Eisenberg et al., 1984), there is no available information on the effect of this on the activity of aminoglycoside-inactivating enzymes. In the case of AAC(6'), we have shown that the different functional groups in the antibiotic moiety influence the kinetic constants of the aminoglycoside-modifying-enzymes and hence help to determine the resistance to one specific aminoglycoside. Since ph affects the ionization state not only of these groups, but also of the groups of the amino-acids at the active site of the enzyme, this parameter may influence the antibiotic resistance mediated by AAQ60. We have shown that, in all cases, the values of V^/Km increased with ph, whereas this was not true for the values of K- At acidic ph, substrate inhibition did not occur. When ph increased, the values of K decreased for kanamycins, whereas they increased for gentamicins (Table II). Therefore, at neutral ph, substrate inhibition could be relevant for the kanamycins, whereas it is not important for the gentamicins. In fact, this inhibition counteracted the high value shown by V^/KM at high ph in the case of amikacin but not of tobramycin. Thus, at ph 7.5, amikacin was more effective than tobramycin and gentamicin against staphylococci harbouring AAC(6'). Despite the ten-fold lower value of Vm^/K m for netilmicin than for amikacin, substrate inhibition produced by amikacin resulted in there being less difference between MICs than might be anticipated. A similar effect was also detectable at ph 6.5, but differences in favour of amikacin were less marked because of the lower inhibition observed at this ph. At ph 5.5, the effect of substrate inhibition was overcome by the decrease in aminoglycoside permeability at low ph. The effect of ph on substrate inhibition may be important in clinical practice, and should also be considered in the design and development of new aminoglycosides. Our data indicate not only that aminoglycosides with glucosamine moeities interact with enzymes in a different way from those with garosamine, but also that kinetic constants for both groups of antibiotics vary in opposite directions in response to ph changes. The effect of ph on the kinetic constants of the /Mactamase TEM-1, as well as on the activity of different /J-lactam antibiotics against TEM-1-producing bacteria have been described previously (Livermore & Corkill, 1992). Detailed studies on the effect of ph on the activity of aminoglycoside-modifying enzymes have been published (Gates & Northrop, 1988), but we believe that this is the first report of the relationship between this effect and the activity of aminoglycosides against AAC(6') producing bacteria. These data point to a role of ph in modulating antibiotic resistance mediated by inactivating enzymes. The effect is seen not only on enzymatic activity {V^K^ and K,) but on the permeability of the organism for the antibiotic as well. Since antibiotics and enzymes (even those belonging to the same family) respond differently to ph changes, much more work is needed to clarify the role of this physiological effector on the mechanisms of antibiotic resistance. The understanding of this modulation might contribute to the development of new therapeutic protocols and to the design of new antibiotics. References Bongaerts, G. P. & Molendijik, L. (1984). Relation between aminoglycoside 2'-O-nucleotidyltransferasc activity and aminoglycoside resistance. Antimicrobial Agents and Chemotherapy 25,
8 888 E. Culebras el al. Bongaerts, G. P. & Vliegenthart, J. S. (1988). Effect of aminoglycoside concentration on reaction rates of aminoglycoside-modifying enzymes. Antimicrobial Agents and Chemotherapy 32, Booth, I. R. (1985). Regulation of cytoplasmic ph in bacteria. Microbiological Reviews 49, Bryan, L. E. (1984). Mechanisms of action of aminoglycoside antibiotics. In Contemporary Issues in Infectious Diseases, Vol. 1. New Dimensions in Antimicrobial Therapy (Root, R. K. & Sande, M. A., Eds), pp Churchill Livingstone, Edinburgh. Culebras, E., Perez-Diaz, J. C, Blazquez, J., Alonso, R. & Baquero, F. (1994). In-vitro synergy between aminogjycosides deployed against Staphylococcus spp. harbouring an 6'-aminoglycoside acetyltransferase, 2"-aminoglycoside phosphotransferase enzyme. Journal of Antimicrobial Chemotherapy 33, Damper, P. D. & Epstein, W. (1981). Role of the membrane potential in bacterial resistance to aminogjycoside antibiotics. Antimicrobial Agents and Chemotherapy 20, Davies, J. (1994). Inactivation of antibiotics and the dissemination of resistance genes. Science 264, de Lencastre, H., de Jonge, B. L., Matthews, P. R. & Tomasz, A. (1994). Molecular aspects of methicillin resistance in Staphvlococcus aureus. Journal of Antimicrobial Chemotherapy 33, Dri, A. & Moreau, V. (1994). Control of the LexA regulon by ph: evidence for a reversible inactivation of the LexA repressor during the growth cycle of Escherichia coli. Molecular Microbiology 12, Eisenberg, E. S., Mandel, L. J., Kaback, H. R. & Miller, M. H. (1984). Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus. Journal of Bacteriology 157, Gates, C. A. & Northrop, D. B. (1988). Determination of the rate-limiting segment of aminoglycoside nucleotidyltransferase 2"-I by ph- and viscosity-dependent kinetics. Biochemistry 27, Graham, D. R. (1981). Gentamicin-resistant staphylococci. Lancet ii, 698. Gudmundsson, A., Erlendsdottir, H., Gottfredsson, M. & Gudmundsson, S. (1991). Impact of ph and cationic supplementation on in vitro postantibiotic effect. Antimicrobial Agents and Chemotherapy 35, Guimaraes, M. H., Sage, R. & Noone, P. (1985). The comparative activity of eleven aminocyclitol antibiotics against 773 aerobic Gram-negative rods and staphylococci isolated from infected hospitalized patients. Journal of Antimicrobial Chemotherapy 16, Haas, M. J. & Dowding, J. E. (1975). Aminoglycoside-modifying enzymes. Methods in Enzymology 43, Hamill, R. J. & Maki, D. K. (1986). Endotoxin shock in man caused by gram-negative bacilli. In Handbook of Endotoxin, Vol. 4. Clinical Aspects of Endotoxin Shock (Proctor, R. A., Ed.), pp Elsevier Science Publishers B. V. Amsterdam. Le Goffic, F., Moreau, N. & Masson, M. (1977). Are some aminoglycoside antibiotics inactivating enzymes polyfunctional? Annales de Microbwlogie 128B, Livermore, D. M. & Corkill, J. E. (1992). Effects of CO, and ph on inhibition of TEM-1 and other /Mactamases by penicillanic acid sulfones. Antimicrobial Agents and Chemotherapy 36, Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C, John, J. F., Korvick, J. A. et al. (1993). Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. American Journal of Medicine 94, National Committee for Clinical Laboratory Standards. (1990). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically Second Edition: Approved Standard M7-A2. NCCLS. Villanova, PA. Olson, E. R. (1993). Influence of ph on bacterial gene expression. Molecular Microbiology 8, Radika, K. & Northrop, D. B. (1984). Correlation of antibiotic resistance with V^K, ratio of enzymatic modification of aminoglycosides by kanamycin acetyltransferase. Antimicrobial Agents and Chemotherapy 25,
9 ph regulation of AAC(60 activity 889 Swartz, M. N. (1994). Hospital-acquired infections: diseases with increasingly limited therapies. Proceedings of the National Academy of Sciences USA 91, Thrupp, L. D. (1980). Susceptibility testing of antibiotics in liquid media. In Antibiotics in Laboratory Medicine (Lorian, V., Ed.), pp Williams & Wilkins Co., Baltimore. Umezawa, Y., Yagisawa, M., Sawa, T., Takeuchi, T. & Umezawa, H. (1975). Aminoglycoside 3'-phosphotransferase III, a new phosphotransferase resistance mechanism. Journal of Antibiotics 28, Wiedemann, B. & Krcsken, M. (1984). The incidence and development of resistance in Staphylococcus aureus from three European countries. Journal of Antimicrobial Chemotherapy 14, Suppl. D, Williams, J. W. & Northrop, D. B. (1978). Substrate specificity and structure-activity relationships of gentamicin acetyltransferase I. Journal of Biological Chemistry 253, {Received 25 July 1995; returned 22 August 1995; revised 15 September 1995; accepted 28 December 1995)
Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1996, p. 35 39 Vol. 40, No. 1 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa
More informationAn evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage
Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",
More informationPlasmid-Mediated Aminoglycoside Phosphotransferase of
ANTIMICROBIAL AGENTS AND CHzMoTHzRAPY, Apr. 1977, p. 619-624 Copyright C 1977 American Society for Microbiology Vol. 11, No. 4 Printed in U.S.A. Plasmid-Mediated Aminoglycoside Phosphotransferase of Broad
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationDerivative, 4'-Deoxy, 6'-N-Methylamikacin
ANTIMICROBLAL AGENTS AND CHEMOTHERAPY, Apr. 1981, p. 549-555 0066-4804/81/040549-07$02.00/0 Vol. 19, No. 4 Resistance to Antibiotic Synergism in Streptococcus faecalis: Further Studies with Amikacin and
More informationConsequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationMID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance
Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationAntimicrobial Resistance Acquisition of Foreign DNA
Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple
More informationLab Exercise: Antibiotics- Evaluation using Kirby Bauer method.
Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.
More informationNocardicin A-F,1976, Nocardia uniformis sp. (Fujisawa) Sulfazecin, 1981, Pseudomonas acidophila (Takeda
Cephamycins Cephamycins Antibiotics III. Cephamycin A-C, 1971, Str. lipmanii 7 -Methoxy group: Somewhat diminished antibacterial activity Resistant to a wide range of ß-lactamase enzymes 3-CH 2 -carbamoyl
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationIn Vitro Activity of Netilmicin, Gentamicin, and Amikacin
ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Jan. 1977, p. 126-131 Copyright X 1977 American Society for Microbiology Vol. 11, No. 1 Printed in U.S.A. In Vitro Activity of Netilmicin, Gentamicin, and Amikacin
More informationSynergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci
Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious
More informationTRANSFERABLE RESISTANCE AND AMINOGLYCOSIDE-MODIFYING ENZYMES IN ENTEROCOCCI
J. MED. MICROBIOL. VOL.-20 (1985) 187-196 0 1985 The Pathological Society of Great Britain and Ireland TRANSFERABLE RESISTANCE AND AMINOGLYCOSIDE-MODIFYING ENZYMES IN ENTEROCOCCI H. Y. CHEN* AND J. D.
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of Change in the approach to the administration of empiric antimicrobial therapy Increased
More informationWHY IS THIS IMPORTANT?
CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change
More informationagainst Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationMechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More informationBoosting Bacterial Metabolism to Combat Antibiotic Resistance
Boosting Bacterial Metabolism to Combat Antibiotic Resistance The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation As Published
More informationMICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2000, p. 1062 1066 Vol. 44, No. 4 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. In Vitro Activities of Daptomycin,
More informationDynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus
2011 International Conference on Biomedical Engineering and Technology IPCBEE vol.11 (2011) (2011) IACSIT Press, Singapore Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus
More informationMicrobiology ( Bacteriology) sheet # 7
Microbiology ( Bacteriology) sheet # 7 Revision of last lecture : Each type of antimicrobial drug normally targets a specific structure or component of the bacterial cell eg:( cell wall, cell membrane,
More informationInhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug
More informationInterpretative reading of the antibiogram. Luis Martínez-Martínez Service of Microbiology University Hospital Marqués de Valdecilla Santander, Spain
Interpretative reading of the antibiogram Luis Martínez-Martínez Service of Microbiology University Hospital Marqués de Valdecilla Santander, Spain ANTIBIOGRAM RESISTANCE SUSCEPTIBILITY ANTIMICROBIAL AGENT
More informationFactors affecting plate assay of gentamicin
Journal of Antimicrobial Chemotherapy (1977) 3, 17-23 Factors affecting plate assay of gentamicin II. Media D. C. Shanson* and C. J. Hince Department of Medical Microbiology, The London Hospital Medical
More informationBurn Infection & Laboratory Diagnosis
Burn Infection & Laboratory Diagnosis Introduction Burns are one the most common forms of trauma. 2 million fires each years 1.2 million people with burn injuries 100000 hospitalization 5000 patients die
More informationIntroduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationby adding different antibiotics to sera containing
J. clin. Path., 1977, 30, 521-525 Serum gentamicin assays of 100 clinical serum samples by a rapid 40 C Kiebsiella method compared with overnight plate diffusion and acetyltransferase assays D. C. SHANSONI
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationAntimicrobials & Resistance
Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)
More informationESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL
ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance
More informationAntibiotics & Resistance
What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed
More informationChristiane Gaudreau* and Huguette Gilbert
Journal of Antimicrobial Chemotherapy (1997) 39, 707 712 JAC Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter
More informationOrigins of Resistance and Resistance Transfer: Food-Producing Animals.
Origins of Resistance and Resistance Transfer: Food-Producing Animals. Chris Teale, AHVLA. Origins of Resistance. Mutation Brachyspira hyodysenteriae and macrolide and pleuromutilin resistance. Campylobacter
More informationPostantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method
Journal of Antimicrobial Chemotherapy (1988) 22, 23-33 Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method Barforo Isaksson'*, Lennart Nibson*, Rolf Mailer' and
More informationAntibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi
Antibacterial therapy 1 د. حامد الزعبي Dr Hamed Al-Zoubi ILOs Principles and terms Different categories of antibiotics Spectrum of activity and mechanism of action Resistancs Antibacterial therapy What
More informationIntroduction to antimicrobial agents
Introduction to antimicrobial agents Kwan Soo Ko Action mechanisms of antimicrobials Bacteriostatic agents, such as tetracycline - Inhibit the growth and multiplication of bacteria - Upon exposure to a
More informationJan A. Jacobs* and Ellen E. Stobberingh
Journal of Antimicrobial Chemotherapy (996) 37, 37-375 In-vitro antimicrobial susceptibility of the 'Streptococcus millerv group {Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius)
More informationAntimicrobial agents
Bacteriology Antimicrobial agents Learning Outcomes: At the end of this lecture, the students should be able to: Identify mechanisms of action of antimicrobial Drugs Know and understand key concepts about
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationMili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh
Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original
More informationComparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae
ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Oct. 1976, P. 592-597 Copyright 1976 American Society for Microbiology Vol. 1, No. 4 Printed in U.S.A. Comparative Activity of Netilmicin, Gentamicin, Amikacin, and
More informationProtein Synthesis Inhibitors
Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors
More informationAminoglycoside-resistant enterococci
Aminoglycoside-resistant enterococci M. J. BASKER, B. SLOCOMBE, AND R. SUTHERLAND From Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey J. clin. Path., 1977, 30, 375-380 SUMMARY
More informationSelective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016
Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that
More informationNo-leaching. No-resistance. No-toxicity. >99.999% Introducing BIOGUARD. Best-in-class dressings for your infection control program
Introducing BIOGUARD No-leaching. >99.999% No-resistance. No-toxicity. Just cost-efficient, broad-spectrum, rapid effectiveness you can rely on. Best-in-class dressings for your infection control program
More informationWhy we perform susceptibility testing
22 nd June 2015 Why we perform susceptibility testing Robin A Howe Antimicrobial use in Primary Care Why do we perform AST? Clinical Clinical Prediction Prediction of of Efficacy Efficacy Why do we perform
More informationAntibiotic Susceptibility of Pseudomonas aeruginosa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1978, p. 979-984 0066-4804/78/0013-0979$02.00/0 Copyright ) 1978 American Society for Microbiology Vol. 13, No. 6 Printed in U.S.A. Effect of Triethylenetetramine
More informationRecommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee
VICH GL27 (ANTIMICROBIAL RESISTANCE: PRE-APPROVAL) December 2003 For implementation at Step 7 - Final GUIDANCE ON PRE-APPROVAL INFORMATION FOR REGISTRATION OF NEW VETERINARY MEDICINAL PRODUCTS FOR FOOD
More informationESCMID Online Lecture Library. by author
Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationBrief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents
Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische
More informationR-factor mediated trimethoprim resistance: result of two three-month clinical surveys
Journal of Clinical Pathology, 1978, 31, 850-854 R-factor mediated trimethoprim resistance: result of two three-month clinical surveys S. G. B. AMYES1, A. M. EMMERSON2, AND J. T. SMITH3 From the 'Department
More informationavailable. and P. aeruginosa resistant to gentamicin by standardized disk testing (1) in the Microbiology Laboratory
ANTimICROBIAL AGENTh AND CHEMOTHERAPY, OCt. 1976, p. 677-681 Copyright 1976 American Society for Microbiology Vol. 10, No. 4 Printed in U.S.A. In Vitro Susceptibility of Gentamicin-Resistant Enterobacteriaceae
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationActivity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
Journal of Antimicrobial Chemotherapy Advance Access published July 31, 2010 J Antimicrob Chemother doi:10.1093/jac/dkq278 Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia
More informationEvaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1987, p. 546-550 0095-1137/87/030546-05$02.00/0 Copyright C 1987, American Society for Microbiology Vol. 25, No. 3 Evaluation of the AutoMicrobic System for Susceptibility
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationUDC: : :579.22/ :615.28
www.imiamn.org.ua /journal.htm 8 UDC: 6.33:61.017.1:579./.841.9:6.8 SUBSTANTIATION OF OVERCOMING OF ANTIBIOTIC RESISTANCE IN ACINETOBACTER BAUMANNII CLINICAL STRAINS BY USAGE OF DECAMETHOXINUM Nazarchuk
More informationMechanisms and Pathways of AMR in the environment
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
More informationTitle: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic
AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:0./aac.0070-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationPrinciples of Antimicrobial therapy
Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or
More informationمادة االدوية المرحلة الثالثة م. غدير حاتم محمد
م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationComparison of antibiotic susceptibility results obtained with Adatab* and disc methods
J Clin Pathol 1984;37:159-165 Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods JJS SNELL, MVS DANVERS, PS GARDNER From the Division of Microbiological Reagents and
More informationPharmacological Evaluation of Amikacin in Neonates
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1975, p. 86-90 Copyright 0 1975 American Society for Microbiology Vol. 8, No. 1 Printed in U.SA. Pharmacological Evaluation of Amikacin in Neonates JORGE B.
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationVOL. XXX NO. 8 THE JOURNAL OF ANTIBIOTICS 655 RESISTANCE OF BACTERIA TO THE NEWER AMINOGLYCOSIDE ANTIBIOTICS: AN EPIDEMIOLOGICAL AND ENZYMATIC STUDY
VOL. XXX NO. 8 THE JOURNAL OF ANTIBIOTICS RESISTANCE OF BACTERIA TO THE NEWER AMINOGLYCOSIDE ANTIBIOTICS: AN EPIDEMIOLOGICAL A ENZYMATIC STUDY MARLYSE DEVAUD, FRITZ H. KAYSER and URSUL.A HUBER Institute
More informationAdvance Access published September 16, 2004
Advance Access published September 16, 2004 Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkh435 JAC Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and
More informationReceived 17 December 2003; accepted 22 December 2003
Journal of Antimicrobial Chemotherapy (2004) 53, 609 615 DOI: 10.1093/jac/dkh130 Advance Access publication 3 March 2004 In vitro post-antibiotic effect of fluoroquinolones, macrolides, β-lactams, tetracyclines,
More informationUSA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION
VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS
More informationEvaluation of the BIOGRAM Antimicrobial Susceptibility Test System
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility
More informationAntibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus
B-O-021 Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus Nongluk Autarkool *a, Yothin Teethaisong a, Sajeera Kupittayanant b, Griangsak Eumkeb a
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin
ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria
More informationReceived 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3112 3118 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3112 3118.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062
More informationDetermination of antibiotic sensitivities by the
Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,
More informationβ-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018
β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa 12-14 March 2018 Antibiotic resistance center Institut Pasteur du Maroc Enterobacteriaceae (E. coli, Salmonella, ) S. aureus
More information2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)
Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according
More informationThere are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
More informationPILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996
PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 996 November 996 by Maggie Brett Antibiotic Reference Laboratory ESR Communicable Disease Centre Porirua CONTENTS Page SUMMARY
More informationAntibacterial Agents & Conditions. Stijn van der Veen
Antibacterial Agents & Conditions Stijn van der Veen Antibacterial agents & conditions Antibacterial agents Disinfectants: Non-selective antimicrobial substances that kill a wide range of bacteria. Only
More informationANTIMICROBIAL TESTING. with ALKA VITA (ALKAHYDROXY ) ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE
ANTIMICROBIAL TESTING with ALKA VITA (ALKAHYDROXY ) on ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE FINAL RESULTS OF ANTIBACTERIAL TESTS IN VITRO WITH THE PRODUCT
More informationD-Lactic Acid Production as a Monitor of the Effectiveness
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1991, p. 237-241 Vol. 35, No. 2 0066-4804/91/020237-05$02.00/0 Copyright 1991, American Society for Microbiology D-Lactic Acid Production as a Monitor of the
More informationStudies on Antibiotic Synergism Against Enterococci
Studies on Antibiotic Synergism Against Enterococci II. EFFECT OF VARIOUS ANTIBIOTICS ON THE UPTAKE OF 4C-LABELED STREPTOMYCIN BY ENTEROCOCCI ROBERT C. MOELLERING, JR. and ARNOLD N. WEINBERG From the Infectious
More informationIn Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone
More informationANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ
ANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ Antibiotic resistance is rapidly emerging as a public health issue throughout the world. Mankind has enjoyed about half a century of virtual complete control
More informationThe pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,
More informationThe Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University
The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3 Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University Tae-yoon Choi ABSTRACT BACKGROUND: The use of disinfectants
More informationTest Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants
Study Title Antibacterial Activity and Efficacy of E-Mist Innovations' Electrostatic Sprayer Product with Multiple Disinfectants Method Modified Association of Analytical Communities Method 961.02 Modified
More informationAntibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017
Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,
More information